Found: 12
Select item for more details and to access through your institution.
Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST Patients.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 6, p. 627, doi. 10.1007/s11523-022-00926-6
- By:
- Publication type:
- Article
Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary Teams.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 6, p. 709, doi. 10.1007/s11523-022-00925-7
- By:
- Publication type:
- Article
Prediction of Resistance Mutations Against Upcoming Anaplastic Lymphoma Kinase Inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Methods for Estimating Long-Term Outcomes for Trastuzumab Deruxtecan in HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 6, p. 727, doi. 10.1007/s11523-022-00922-w
- By:
- Publication type:
- Article
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 6, p. 643, doi. 10.1007/s11523-022-00921-x
- By:
- Publication type:
- Article
Do Early Phase Oncology Trials Predict Clinical Efficacy in Subsequent Biomarker-Enriched Phase III Randomized Trials?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Acknowledgement to Referees.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 6, p. 611, doi. 10.1007/s11523-022-00924-8
- Publication type:
- Article
Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET gene.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 6, p. 675, doi. 10.1007/s11523-022-00915-9
- By:
- Publication type:
- Article
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2− Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 6, p. 615, doi. 10.1007/s11523-022-00913-x
- By:
- Publication type:
- Article
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article